David Gregory, PhD
Dr Gregory is a molecular biologist with over 15 years’ experience in innate immunity and infectious disease. A 2020 recruit to VIC, he contributes to strategic management of the High Dimensional Immunology platform together with multiple projects and external collaborations. He leads aspects of our COVID portfolio.
Dr Gregory has an extensive background in applying genome-scale analyses to neglected and emerging infectious disease. His postdoctoral studies focused on the effects of infection with a neglected tropical parasite on gene expression, and how this influences clinical outcome. He then spent 10 years at Harvard T.H. Chan School of Public Health developing genomic and bioinformatic screening techniques to identify genes that make people susceptible to emerging, neglected, and defense-related respiratory pathogens, including the bacteria that cause plague, anthrax, tularemia, and tuberculosis. At MGH, he previously lead a cross-functional data analysis and interpretation team in a consortium to develop a novel therapeutic paradigm for fatal systemic inflammation. He now applies this experience to VIC’s complex, data-intense programs and studies of COVID immunology.